XML 102 R88.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidating Financial Statements (Cash Flow) (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Cash flows from operating activities:    
Net cash provided by (used in) operating activities $ 171,687 $ 116,972
Cash flows from investing activities:    
Capital expenditures (22,053) (11,942)
Return of capital from investees 3,908 172
Investment in and loans to investees 0 (42,318)
Payments for acquisition of a business, net of cash acquired 0  
Increase (decrease) to investment in affiliates 0 0
Net cash used in investing activities (18,145) (54,088)
Cash flows from financing activities:    
Deemed repurchases of restricted stock units (22,959) (15,354)
Purchase of treasury stock (991) (83,637)
Proceeds from stock option exercises 4,630 0
Principal payments on finance lease obligations (1,309) (1,406)
Distributions to noncontrolling interests (5,629) (1,435)
Proceeds from the issuance of long-term debt 2,521 0
Principal payments on long-term debt (3,238) 0
Payments for financing costs   0
Net cash used in financing activities (26,975) (101,832)
Net increase (decrease) in cash and cash equivalents from operations 126,567 (38,948)
Effect of exchange rate changes on cash and cash equivalents 2,229 9,365
Cash and cash equivalents at beginning of period 554,886 558,783
Cash and cash equivalents at end of period 683,682 529,200
Eliminations    
Cash flows from operating activities:    
Net cash provided by (used in) operating activities (217,930) (264,998)
Cash flows from investing activities:    
Capital expenditures 0 0
Return of capital from investees 0 0
Investment in and loans to investees 0 0
Payments for acquisition of a business, net of cash acquired 0  
Increase (decrease) to investment in affiliates 183,451 203,739
Net cash used in investing activities 183,451 203,739
Cash flows from financing activities:    
Deemed repurchases of restricted stock units 0 0
Purchase of treasury stock 0 0
Proceeds from stock option exercises 0  
Principal payments on finance lease obligations 0 0
Distributions to noncontrolling interests 0 0
Proceeds from the issuance of long-term debt 0 0
Principal payments on long-term debt 0 0
Payments for financing costs   0
Net cash used in financing activities 0 0
Net increase (decrease) in cash and cash equivalents from operations (34,479) (61,259)
Effect of exchange rate changes on cash and cash equivalents 34,479 61,259
Cash and cash equivalents at beginning of period 0 0
Cash and cash equivalents at end of period 0 0
Parent Company    
Cash flows from operating activities:    
Net cash provided by (used in) operating activities 197,776 234,947
Cash flows from investing activities:    
Capital expenditures (26) 0
Return of capital from investees 0 0
Investment in and loans to investees 0 0
Payments for acquisition of a business, net of cash acquired 0  
Increase (decrease) to investment in affiliates (177,117) (141,109)
Net cash used in investing activities (177,143) (141,109)
Cash flows from financing activities:    
Deemed repurchases of restricted stock units (22,959) (15,354)
Purchase of treasury stock (991) (83,637)
Proceeds from stock option exercises 4,630  
Principal payments on finance lease obligations 0 0
Distributions to noncontrolling interests 0 0
Proceeds from the issuance of long-term debt 0 0
Principal payments on long-term debt 0 0
Payments for financing costs   0
Net cash used in financing activities (19,320) (98,991)
Net increase (decrease) in cash and cash equivalents from operations 1,313 (5,153)
Effect of exchange rate changes on cash and cash equivalents (607) 5,017
Cash and cash equivalents at beginning of period 121 320
Cash and cash equivalents at end of period 827 184
Guarantor Subsidiaries    
Cash flows from operating activities:    
Net cash provided by (used in) operating activities 164,138 154,495
Cash flows from investing activities:    
Capital expenditures (19,868) (11,040)
Return of capital from investees 0 0
Investment in and loans to investees 0 0
Payments for acquisition of a business, net of cash acquired 0  
Increase (decrease) to investment in affiliates 69,120 (129,821)
Net cash used in investing activities 49,252 (140,861)
Cash flows from financing activities:    
Deemed repurchases of restricted stock units 0 0
Purchase of treasury stock 0 0
Proceeds from stock option exercises 0  
Principal payments on finance lease obligations (786) (723)
Distributions to noncontrolling interests 0 0
Proceeds from the issuance of long-term debt 0 0
Principal payments on long-term debt 0 0
Payments for financing costs   0
Net cash used in financing activities (786) (723)
Net increase (decrease) in cash and cash equivalents from operations 212,604 12,911
Effect of exchange rate changes on cash and cash equivalents (102,939) (49,740)
Cash and cash equivalents at beginning of period 368,151 391,248
Cash and cash equivalents at end of period 477,816 354,419
Non- Guarantor Subsidiaries    
Cash flows from operating activities:    
Net cash provided by (used in) operating activities 27,703 (7,472)
Cash flows from investing activities:    
Capital expenditures (2,159) (902)
Return of capital from investees 3,908 172
Investment in and loans to investees 0 (42,318)
Payments for acquisition of a business, net of cash acquired 0  
Increase (decrease) to investment in affiliates (75,454) 67,191
Net cash used in investing activities (73,705) 24,143
Cash flows from financing activities:    
Deemed repurchases of restricted stock units 0 0
Purchase of treasury stock 0 0
Proceeds from stock option exercises 0  
Principal payments on finance lease obligations (523) (683)
Distributions to noncontrolling interests (5,629) (1,435)
Proceeds from the issuance of long-term debt 2,521 0
Principal payments on long-term debt (3,238) 0
Payments for financing costs   0
Net cash used in financing activities (6,869) (2,118)
Net increase (decrease) in cash and cash equivalents from operations (52,871) 14,553
Effect of exchange rate changes on cash and cash equivalents 71,296 (7,171)
Cash and cash equivalents at beginning of period 186,614 167,215
Cash and cash equivalents at end of period $ 205,039 $ 174,597